2 ADJACENT N-TERMINAL GLUTAMINES OF BM-40 (OSTEONECTIN, SPARC) ACT AS AMINE ACCEPTOR SITES IN TRANSGLUTAMINASE(C)-CATALYZED MODIFICATION

被引:50
作者
HOHENADL, C
MANN, K
MAYER, U
TIMPL, R
PAULSSON, R
AESCHLIMANN, D
机构
[1] MAX PLANCK INST BIOCHEM,DEPT PROT CHEM,D-82152 MARTINSRIED,GERMANY
[2] UNIV BERN,ME MULLER INST BIOMECH,CH-3010 BERN,SWITZERLAND
[3] UNIV COLOGNE,FAC MED,INST BIOCHEM,D-50931 COLOGNE,GERMANY
[4] UNIV WISCONSIN,DEPT MED,MADISON,WI 53706
关键词
D O I
10.1074/jbc.270.40.23415
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The extracellular matrix protein BM-40 (osteonectin, SPARC) has recently been shown to be a major target for transglutaminase catalyzed cross-linking in differentiating cartilage. In the present study we demonstrate that recombinant human BM-40 can be modified with [H-3]putrescine in a 1:1 molar ratio by transglutaminase(C) (tissue transglutaminase). Residues Gln(3) and Gln(4) were identified as major amine acceptor sites, This was confirmed with several mutant proteins, including deletions in the N-terminal domain I of BM-40, site-directed mutagenesis of the reactive glutamines, and fusion of the seven-amino acid-long N-terminal sequence (APQQEAL) to an unrelated protein, The results showed that the N-terminal target site is sufficient for modification by transglutaminase but at a low level, For high efficiency amine incorporation an intact domain I is required, The conservation of at least one of the transglutaminase target glutamines in the known vertebrate BM-40 sequences and their absence in an invertebrate homologue point to an important, but yet unknown, role of this modification in vertebrates.
引用
收藏
页码:23415 / 23420
页数:6
相关论文
共 42 条
[1]   TRANSGLUTAMINASE-CATALYZED MATRIX CROSS-LINKING IN DIFFERENTIATING CARTILAGE - IDENTIFICATION OF OSTEONECTIN AS A MAJOR GLUTAMINYL SUBSTRATE [J].
AESCHLIMANN, D ;
KAUPP, O ;
PAULSSON, M .
JOURNAL OF CELL BIOLOGY, 1995, 129 (03) :881-892
[2]  
AESCHLIMANN D, 1991, J BIOL CHEM, V266, P15308
[3]  
AESCHLIMANN D, 1992, J BIOL CHEM, V267, P11316
[4]   EXPRESSION OF TISSUE TRANSGLUTAMINASE IN SKELETAL TISSUES CORRELATES WITH EVENTS OF TERMINAL DIFFERENTIATION OF CHONDROCYTES [J].
AESCHLIMANN, D ;
WETTERWALD, A ;
FLEISCH, H ;
PAULSSON, M .
JOURNAL OF CELL BIOLOGY, 1993, 120 (06) :1461-1470
[5]  
AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402
[6]   MOLECULAR ANALYSIS OF CHICKEN-EMBRYO SPARC (OSTEONECTIN) [J].
BASSUK, JA ;
IRUELAARISPE, ML ;
LANE, TF ;
BENSON, JM ;
BERG, RA ;
SAGE, EH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 218 (01) :117-127
[7]   LENS TRANSGLUTAMINASE SELECTS SPECIFIC BETA-CRYSTALLIN SEQUENCES AS SUBSTRATE [J].
BERBERS, GAM ;
FEENSTRA, RW ;
VANDENBOS, R ;
HOEKMAN, WA ;
BLOEMENDAL, H ;
DEJONG, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (22) :7017-7020
[8]   OSTEONECTIN CDNA SEQUENCE REVEALS POTENTIAL BINDING REGIONS FOR CALCIUM AND HYDROXYAPATITE AND SHOWS HOMOLOGIES WITH BOTH A BASEMENT-MEMBRANE PROTEIN (SPARC) AND A SERINE PROTEINASE-INHIBITOR (OVOMUCOID) [J].
BOLANDER, ME ;
YOUNG, MF ;
FISHER, LW ;
YAMADA, Y ;
TERMINE, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (09) :2919-2923
[9]   LAMBDA-LAMBDA CROSS-LINKING SITES IN HUMAN AND BOVINE FIBRIN [J].
CHEN, R ;
DOOLITTLE, RF .
BIOCHEMISTRY, 1971, 10 (24) :4486-+
[10]   COMPLEX-FORMATION OF HUMAN THROMBOSPONDIN WITH OSTEONECTIN [J].
CLEZARDIN, P ;
MALAVAL, L ;
EHRENSPERGER, AS ;
DELMAS, PD ;
DECHAVANNE, M ;
MCGREGOR, JL .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 175 (02) :275-284